Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

247 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
Velasquez WS, McLaughlin P, Fuller LM, Allen PK, Tucker SL, Swan F Jr, Rodriguez MA, Hagemeister FB, Cabanillas FF. Velasquez WS, et al. Among authors: allen pk. Cancer. 1994 May 1;73(9):2408-16. doi: 10.1002/1097-0142(19940501)73:9<2408::aid-cncr2820730926>;2-m. Cancer. 1994. PMID: 7513251
Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation.
Fuller LM, Krasin MJ, Velasquez WS, Allen PK, McLaughlin P, Rodriguez MA, Hagemeister FB, Swan F Jr, Cabanillas F, Palmer JL, et al. Fuller LM, et al. Among authors: allen pk. Int J Radiat Oncol Biol Phys. 1995 Jan 1;31(1):3-11. doi: 10.1016/0360-3016(94)00343-J. Int J Radiat Oncol Biol Phys. 1995. PMID: 7527799 Clinical Trial.
Prognostic role of serum beta 2-microglobulin in Hodgkin's disease.
Dimopoulos MA, Cabanillas F, Lee JJ, Swan F, Fuller L, Allen PK, Hagemeister FB. Dimopoulos MA, et al. Among authors: allen pk. J Clin Oncol. 1993 Jun;11(6):1108-11. doi: 10.1200/JCO.1993.11.6.1108. J Clin Oncol. 1993. PMID: 8501496
247 results